Cargando…

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models

SIMPLE SUMMARY: Microtubule-targeting agents are a class of chemotherapeutics used to treat triple-negative breast cancer (TNBC). These include drugs such as eribulin that depolymerize microtubules, as well as microtubule stabilizing taxanes such as paclitaxel. TNBC is a relatively immunogenic form...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi-Ruiz, Leila, Fermaintt, Charles S., Wilkinson, Nancy J., Chan, Peter Y. W., Mooberry, Susan L., Risinger, April L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740651/ https://www.ncbi.nlm.nih.gov/pubmed/36497445 http://dx.doi.org/10.3390/cancers14235962

Ejemplares similares

429 Eribulin Synergizes with STING Agonists by Enhancing Type 1 Interferon Expression and Improves Antitumor Efficacy as Combination Treatment
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2023)

Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA
por: Fermaintt, Charles S., et al.
Publicado: (2021)

Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas/Src inhibition by eribulin
por: Dybdal-Hargreaves, Nicholas F., et al.
Publicado: (2017)

Correction: Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130CAS/Src inhibition by eribulin
por: Dybdal-Hargreaves, Nicholas F., et al.
Publicado: (2019)

Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent manner
por: Kaul, Roma, et al.
Publicado: (2019)

Correction: Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent manner
por: Kaul, Roma, et al.
Publicado: (2020)

Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential
por: Fermaintt, Charles S., et al.
Publicado: (2021)

Synthetic Reactions with Rare Taccalonolides Reveal the Value of C-22,23 Epoxidation for Microtubule Stabilizing Potency
por: Peng, Jiangnan, et al.
Publicado: (2014)

Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer Cells
por: Pederson, Petra J., et al.
Publicado: (2021)

The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation
por: Risinger, April L, et al.
Publicado: (2014)

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer
por: Owusu-Brackett, Nicci, et al.
Publicado: (2019)

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
por: Xie, Xuemei, et al.
Publicado: (2023)

Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer Models
por: Yee, Samantha S., et al.
Publicado: (2021)

In Vivo Evaluation of (−)-Zampanolide Demonstrates Potent and Persistent Antitumor Efficacy When Targeted to the Tumor Site
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2022)

Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines
por: Terashima, Masato, et al.
Publicado: (2014)

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
por: Lemos, Henrique, et al.
Publicado: (2020)

Identification of MSA-2: An oral antitumor non-nucleotide STING agonist
por: Liu, Jianhua, et al.
Publicado: (2021)

An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
por: Liu, Yang, et al.
Publicado: (2019)

Janus Compounds, 5-Chloro-N(4)-methyl-N(4)-aryl-9H-pyrimido[4,5-b]indole-2,4-diamines, Cause Both Microtubule Depolymerizing and Stabilizing Effects
por: Rohena, Cristina C., et al.
Publicado: (2016)

Eribulin mesylate exerts antitumor effects via CD103
por: Oya, Kazumasa, et al.
Publicado: (2023)

Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody
por: Niwa, Yuki, et al.
Publicado: (2023)

A Non-Nucleotide STING Agonist MSA-2 Synergized with Manganese in Enhancing STING Activation to Elicit Potent Anti-RNA Virus Activity in the Cells
por: Lin, Hanrui, et al.
Publicado: (2023)

STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
por: Zhang, Bo-Dou, et al.
Publicado: (2022)

Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context
por: Czapla, Justyna, et al.
Publicado: (2023)

Ectopic A-lattice seams destabilize microtubules
por: Katsuki, Miho, et al.
Publicado: (2014)

TBA-7 is not a microtubule-destabilizing tubulin
por: Lu, Yu-Ming, et al.
Publicado: (2021)

Elucidating target specificity of the taccalonolide covalent microtubule stabilizers employing a combinatorial chemical approach
por: Du, Lin, et al.
Publicado: (2020)

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer
por: Muñoz-Couselo, Eva, et al.
Publicado: (2011)

Microtubule dissassembly in vivo: intercalary destabilization and breakdown of microtubules in the heliozoan Actinocoryne contractilis
Publicado: (1992)

Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2021)

Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
por: Florian, David C., et al.
Publicado: (2023)

Pharmaceutical-Grade Rigosertib Is a Microtubule-Destabilizing Agent
por: Jost, Marco, et al.
Publicado: (2020)

Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy
por: González, Myriam, et al.
Publicado: (2021)

Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
por: Ho, Gwo Yaw, et al.
Publicado: (2022)

Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer
por: Rao, Shreyas S., et al.
Publicado: (2017)

Importin α/β promote Kif18B microtubule association and enhance microtubule destabilization activity
por: Shrestha, Sanjay, et al.
Publicado: (2023)

STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021)

Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein
por: Nabekura, Tomohiro, et al.
Publicado: (2020)

Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models
por: Papaevangelou, Efthymia, et al.
Publicado: (2023)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8pjep716heiv6r4tel4fq19qvb